Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
- Status
- COMPLETED
- Phase
- PHASE3
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE1